Seneca Growth Capital VCT plc Investment Realisations And Nav
16 September 2020 - 4:00PM
UK Regulatory
TIDMHYG TIDMSVCT
Seneca Growth Capital VCT Plc (the "Company")
16 September 2020
Realisations of Ordinary Share Investments and New Ordinary Share Net
Asset Value ("NAV").
Full Realisation of Ordinary Share Investment in Omega Diagnostics Group
plc ("Omega")
Following the recent rise in Omega's share price on AIM, the Company has
sold the remaining 400,000 Omega shares it retained, realising
GBP296,166, an increase of GBP132,166 (unaudited) on their carrying
value as at 30 June 2020, being the date of the most recently announced
NAV per Ordinary Share. The Company has now sold a total of 2,293,868
Omega shares from the Ordinary Share pool since 31 December 2019 fully
realising the investment for a total of GBP987,318 and generating a
profit versus original cost of GBP659,318 (a 3x return on the original
investment).
Partial Realisation of Ordinary Share Investment in Scancell Holdings
Plc ("Scancell")
The Directors are also pleased to report that the Company has sold
1,049,730 Scancell shares from the Ordinary Share pool, realising
GBP126,619 and generating a profit versus original cost of GBP63,110 (a
2x return on the original investment) and an increase of GBP72,033 on
their carrying value as at 30 June 2020. The Company's Ordinary Share
pool retains 12,000,000 Scancell shares.
New Ordinary Share Net Asset Value
The Board have reviewed the carrying value of all Ordinary Share pool
investments, including Scancell at a bid price of 15p per share as at 14
September 2020, and report that as at 14 September 2020 the unaudited
NAV per Ordinary share was 35.8p, an increase of 13.6p per Ordinary
share from the unaudited NAV of 22.2p per Ordinary share (the unaudited
NAV as at 30 June 2020 net of the dividend of 8p per Ordinary Share that
was paid on 28 August 2020). This increase is a result of the profit
generated on the sale of Omega and Scancell shares, and the increase in
value of the remaining Scancell shares, net of the associated movement
in the performance fee accrual.
The information above is deemed by the Company to constitute inside
information as stipulated under the Market Abuse Regulations (EU No.
596/2014). Upon the publication of this announcement via a Regulatory
Information Service this inside information is now considered to be in
the public domain.
For further information, please contact:
John Hustler, Seneca Growth Capital VCT Plc at
https://www.globenewswire.com/Tracker?data=SFI1o_Z6m6HvfkCgstkxYVwc80FvM9twdxXs1EIdj32l7Q-iurfZl9vRwt3QtlNJoc5Wa3UqlpeFTVl7odZMdYnsxDim3uGHE-5IlmaYT4zod9a9Sqwlk-28D7hxLrJA
john.hustler@btconnect.com
Richard Manley, Seneca Growth Capital VCT Plc at
https://www.globenewswire.com/Tracker?data=lT6P9xAswoyxMo4HVcG8LD-0DN5D3O703YVdkJp8KGcqAtHVQCJSwEBJyj_qukXBKKgEQmvumXJgGI5zyPT9mDcKWad8MMVi6Ixa8ZcI_ctOPhF7XPhngy_BAtZeep4jy1S1d1N_yK-vyXfZ2sv2TQ==
Richard.Manley@senecapartners.co.uk
(END) Dow Jones Newswires
September 16, 2020 02:00 ET (06:00 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Seneca Growth Capital Vct (LSE:SVCT)
Historical Stock Chart
From Apr 2024 to May 2024
Seneca Growth Capital Vct (LSE:SVCT)
Historical Stock Chart
From May 2023 to May 2024